Immunoconjugate
|
WikiDoc Resources for Immunoconjugate |
|
Articles |
|---|
|
Most recent articles on Immunoconjugate Most cited articles on Immunoconjugate |
|
Media |
|
Powerpoint slides on Immunoconjugate |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Immunoconjugate at Clinical Trials.gov Trial results on Immunoconjugate Clinical Trials on Immunoconjugate at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Immunoconjugate NICE Guidance on Immunoconjugate
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Immunoconjugate Discussion groups on Immunoconjugate Patient Handouts on Immunoconjugate Directions to Hospitals Treating Immunoconjugate Risk calculators and risk factors for Immunoconjugate
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Immunoconjugate |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Immunoconjugates are antibodies conjugated to a second molecule, usually a toxin, radioisotope or label.[1] These conjugates are used in immunotherapy and to develop monoclonal antibody therapy as a targeted form of chemotherapy.[2]